Effect of nifedipine with and without sildenafil citrate for the management of preterm labor in pregnant women: A randomized clinical trial.

Randomized trial. Sildenafil citrate preterm labor Nifedipine

Journal

International journal of reproductive biomedicine
ISSN: 2476-4108
Titre abrégé: Int J Reprod Biomed
Pays: Iran
ID NLM: 101679102

Informations de publication

Date de publication:
May 2023
Historique:
received: 28 02 2022
revised: 17 12 2022
accepted: 11 03 2023
medline: 26 6 2023
pubmed: 26 6 2023
entrez: 26 6 2023
Statut: epublish

Résumé

Preterm labor is one of the main causes of neonatal mortality and its treatment is still challenging. The study aimed to compare the effectiveness of nifedipine (Nif) with and without sildenafil citrate (SC) for the treatment of preterm labor in pregnant women. In this clinical trial study, 126 pregnant women referred to the Fatemieh hospital, Hamadan, Iran with a complaint of preterm labor were evaluated. Participants were randomly divided into 2 groups of Nif 20 mg orally (single dose), then 10 mg every 6-hr, and at the same time vaginal SC 25 mg every 8 hr (Nif + SC) or Nif alone. Treatment was continued for 48-72 hr if uterine contractions did not resolve in both groups. Delivery rates at the time of hospitalization and neonatal outcome were compared between the 2 groups. No statistically significant difference was observed between the 2 study groups in terms of mean age, gestational age, body mass index, and parity. 76.2% of Nif + SC participants in the first 72 hr of hospitalization and 57.2% of Nif participants remained without delivery (p = 0.02). The neonatal hospitalization rate of the Nif + SC group in the neonatal intensive care unit was 25.4% and in the Nif group was 42.9% (p = 0.03). Nif with SC is superior to Nif alone in women at risk of preterm labor due to increasing gestational age and better neonatal outcomes.

Sections du résumé

Background UNASSIGNED
Preterm labor is one of the main causes of neonatal mortality and its treatment is still challenging.
Objective UNASSIGNED
The study aimed to compare the effectiveness of nifedipine (Nif) with and without sildenafil citrate (SC) for the treatment of preterm labor in pregnant women.
Materials and Methods UNASSIGNED
In this clinical trial study, 126 pregnant women referred to the Fatemieh hospital, Hamadan, Iran with a complaint of preterm labor were evaluated. Participants were randomly divided into 2 groups of Nif 20 mg orally (single dose), then 10 mg every 6-hr, and at the same time vaginal SC 25 mg every 8 hr (Nif + SC) or Nif alone. Treatment was continued for 48-72 hr if uterine contractions did not resolve in both groups. Delivery rates at the time of hospitalization and neonatal outcome were compared between the 2 groups.
Results UNASSIGNED
No statistically significant difference was observed between the 2 study groups in terms of mean age, gestational age, body mass index, and parity. 76.2% of Nif + SC participants in the first 72 hr of hospitalization and 57.2% of Nif participants remained without delivery (p = 0.02). The neonatal hospitalization rate of the Nif + SC group in the neonatal intensive care unit was 25.4% and in the Nif group was 42.9% (p = 0.03).
Conclusion UNASSIGNED
Nif with SC is superior to Nif alone in women at risk of preterm labor due to increasing gestational age and better neonatal outcomes.

Identifiants

pubmed: 37362093
doi: 10.18502/ijrm.v21i5.13471
pmc: PMC10285191
doi:

Types de publication

Journal Article

Langues

eng

Pagination

379-386

Informations de copyright

Copyright © 2023 Nasrolahei et al.

Déclaration de conflit d'intérêts

The authors declare that there is no conflict of interest.

Références

Acta Obstet Gynecol Scand. 2018 Nov;97(11):1388-1395
pubmed: 29797737
J Matern Fetal Neonatal Med. 2020 Oct;33(19):3215-3220
pubmed: 30696306
BMC Pregnancy Childbirth. 2022 Jul 15;22(1):567
pubmed: 35840927
Am J Obstet Gynecol. 2020 May;222(5):401-414
pubmed: 31978434
Am J Obstet Gynecol. 2004 Jul;191(1):315-21
pubmed: 15295385
Curr Pharm Des. 2019;25(5):577-592
pubmed: 30931850
PLoS One. 2019 Jul 24;14(7):e0219732
pubmed: 31339910
Am J Obstet Gynecol. 2010 Sep;203(3):252.e1-5
pubmed: 20541728
J Family Reprod Health. 2021 Jun;15(2):112-117
pubmed: 34721600
Obstet Gynecol Surv. 2019 Jan;74(1):50-55
pubmed: 30648727
Iran J Reprod Med. 2014 Feb;12(2):145-50
pubmed: 24799873
Clin Perinatol. 2019 Jun;46(2):159-172
pubmed: 31010553
Semin Fetal Neonatal Med. 2019 Feb;24(1):27-32
pubmed: 30337215
Lakartidningen. 2019 Oct 8;116:
pubmed: 31593284
BMC Pregnancy Childbirth. 2021 Jun 29;21(1):457
pubmed: 34187394
Fundam Clin Pharmacol. 2021 Apr;35(2):235-259
pubmed: 33226665
Am J Obstet Gynecol. 2011 Feb;204(2):134.e1-20
pubmed: 21284967
EClinicalMedicine. 2022 Jun 03;49:101496
pubmed: 35747187

Auteurs

Shahla Nasrolahei (S)

Department of Obstetrics and Gynecology, School of Medicine Endometrium and Endometriosis Research Center, Fatemieh Hospital, Hamadan University of Medical Sciences, Hamadan, Iran.

Seyedeh Arezoo Hoseini (S)

Department of Obstetrics and Gynecology, Zanjan University of Medical Sciences, Zanjan, Iran.

Seyedeh Azadeh Hosseini (S)

Iran University of Medical Sciences, Tehran, Iran.

Seyedeh Narjes Khatoon Hosseini (S)

Bahçeşehir Medical University Istanbul Turkey, Istanbul, Turkey.

Seyedeh Sahar Hosseini (S)

Bahçeşehir Medical University Istanbul Turkey, Istanbul, Turkey.

Parsa Moradian Lotfi (P)

Hamadan University of Medical Sciences, Hamadan, Iran.

Classifications MeSH